Advertisement
The burden of new-onset atrial fibrillation is considerable following transcatheter aortic valve implantation and surgical aortic valve replacement

Burden of New-Onset A-Fib Considerable After TAVI, AVR

0
Odds of in-hospital mortality increased in TAVI, AVR hospitalization with new-onset atrial fibrillation
For patients with psoriatic disease

Carotid Atherosclerosis Predicts CV Events in Psoriatic Disease

0
After controlling for Framingham Risk Score, TPA, mean and max cIMT predict incident CVEs
There seems to be no evidence of a legacy effect or mortality benefit for intensive glucose control among military veterans with type 2 diabetes

No Evidence of Legacy Effect Seen for Intensive Glucose Lowering

0
Findings based on 15-year follow-up study conducted among veterans with type 2 diabetes
For middle-aged adults

Increase in CV Mortality Smaller With Medicaid Expansion

0
Counties in states that expanded Medicaid had significantly smaller increase in cardiovascular mortality
β-blockers can attenuate the impact of anger or stress on atrial fibrillation

β-Blockers May Moderate Impact of Stress on Atrial Fibrillation

0
Likelihood of atrial fibrillation episode up during anger or stress; β-blockers can attenuate effect

May 2019 Briefing – Cardiology

0
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for May 2019. This roundup includes the latest...
People living with HIV have an increased risk for cardiovascular disease

Guidelines Issued for Addressing Heart Disease Risk in HIV

0
Individuals with HIV have significantly higher rates of CVD, may have underuse of statins, antithrombotics
Providing assistance for physician impairment and rehabilitation is addressed in a position statement issued by the American College of Physicians and published online June 4 in the Annals of Internal Medicine.

ACP Issues Position on Response to Physician Impairment

0
Rehabilitated doctors should be reintegrated into practice as long as patient safety not compromised
Clinical manifestations of systemic lupus erythematosus vary by racial and ethnic groups

Lupus Manifestations Appear to Differ by Race, Ethnicity

0
Increased risk for severe manifestations seen among blacks, Hispanics, and Asians/Pacific Islanders
Taking proton pump inhibitors is associated with an excess of cause-specific mortality

Excess Cause-Specific Mortality Tied to Chronic Proton Pump Inhibitor Use

0
Excess mortality due to CVD, CKD, upper GI cancer for those with no indication for PPI use